Table 1 Detailed Demographics of Cases Selected for Proteomics
From: Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration
Diagnosis | Case # | Â | 1PMI (hr) | Age at Death | Duration | ApoE Status | 2Race/Sex |
|---|---|---|---|---|---|---|---|
| Â | 1 | Â | 4 | 55 | 6 | E3/3 | W/M |
| Â | 2 | Â | 4.5 | 55 | 3 | E3/4 | W/F |
| Â | 3 | Â | 20 | 57 | 7 | E3/4 | B/F |
| Â | 4 | Â | 11.5 | 62 | 10 | E3/4 | W/M |
AD | 5 | Â | 4.5 | 64 | 12 | E3/4 | W/F |
| Â | 6 | Â | 5.5 | 69 | 21 | E4/4 | W/F |
| Â | 7 | Â | 15 | 71 | 2.5 | E3/4 | W/M |
| Â | 8 | Â | 17 | 71 | 8 | E3/4 | W/M |
| Â | 9 | Â | 21 | 76 | 12 | E2/3 | W/F |
| Â | 10 | Â | 12 | 81 | 12 | E3/4 | W/F |
n = 10 | AVG | Â | 11.5 | 66.1 | 9.4 | Â | Â |
| Â | 1 | Â | 3 | 52 | Â | E3/4 | W/F |
| Â | 2 | Â | 10 | 57 | Â | E3/3 | W/M |
| Â | 3 | 3* | 8 | 60 | Â | E3/4 | B/F |
| Â | 4 | Â | 12 | 61 | Â | E3/4 | B/M |
Control | 5 | Â | 12 | 65 | NA | E3/3 | W/M |
| Â | 6 | Â | 6 | 65 | Â | E3/3 | W/F |
| Â | 7 | * | 11 | 68 | Â | E3/3 | W/F |
| Â | 8 | * | 6 | 69 | Â | E3/3 | W/M |
| Â | 9 | Â | 7 | 74 | Â | E3/3 | W/F |
| Â | 10 | * | 6 | 75 | Â | E3/3 | W/F |
n = 10 | AVG | Â | 8.1 | 64.6 | NA | Â | Â |
| Â | 1 | Â | 3 | 41 | 9 | E3/3 | W/M |
| Â | 2 | Â | 17.5 | 61 | 5 | E3/3 | W/M |
| Â | 3 | * | 11.5 | 62 | 10 | E3/3 | A/F |
| Â | 4 | * | 17 | 63 | 7.5 | E3/3 | W/M |
FTLD-U | 5 | Â | 6 | 64 | 8 | E3/4 | W/F |
| Â | 6 | * | NA | 69 | 1 | E3/3 | W/F |
| Â | 7 | Â | NA | 69 | 1 | E3/3 | W/F |
| Â | 8 | Â | 18 | 71 | 9 | E3/3 | W/F |
| Â | 9 | Â | 17 | 74 | 16 | E3/4 | W/M |
| Â | 10 | * | 7 | 83 | 4 | E3/3 | W/F |
n = 10 | AVG | Â | 12.1 | 65.7 | 7.1 | Â | Â |